(Total Views: 639)
Posted On: 08/13/2021 7:37:40 AM
Post# of 154009
This morning's press release appears to indicate that patients are not yet being dosed in Brazilian trials, unfortunately.
Quote:
“This is an exciting period for CytoDyn. With the continuation of the BLA resubmission, the near-term initiation of two important COVID-19 trials in Brazil , and possibly a strong clinical trial in the U.S. for COVID-19 long-haulers, the next two to three months could be transformative for the Company.”/quote]
https://www.cytodyn.com/investors/news-events...v-bla-dose
(2)
(0)
